# llms.txt for Lisata.com

## Site Purpose
Lisata Therapeutics, formed from the merger of Caladrius Biosciences and Cend Therapeutics, is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its lead investigational product candidate, certepetide, is designed to modify the tumor microenvironment by activating a novel uptake pathway that allows anti-cancer drugs to penetrate solid tumors more effectively.

## Primary Audience
- Investors
- Employees
- Patients and Caregivers
- Healthcare Professionals
- Business Partners

## Key Site Sections
- /research-technology — Development portfolio of novel product candidates
- /product-development-pipeline — Proprietary and patented technology platforms designed to identify and treat patients most likely to respond to targeted therapies

## Cornerstone & High-Value Pages
- https://www.lisata.com/clinical-stage-pharmaceutical-company/
- https://www.lisata.com/product-development-pipeline/
- https://www.lisata.com/research-technology/cendr-platform/
- https://www.lisata.com/active-clinical-trials/
- https://www.lisata.com/product-development-pipeline/pancreatic-cancer-advanced-solid-tumors-certepetide/
- https://www.lisata.com/clinical-stage-pharmaceutical-company/management-team/
- https://www.lisata.com/clinical-stage-pharmaceutical-company/board-of-directors/
- https://www.lisata.com/research-technology/publications/
- https://ir.lisata.com/
- https://www.lisata.com/patients-families/cholangiocarcinoma-bile-duct-cancer-symptoms/
- https://www.lisata.com/patients-families/metastatic-pancreatic-ductal-adenocarcinoma-symptoms/

## Publisher & Editorial Standards
Lisata.com is operated by employees of Lisata Therapeutics. All content is reviewed by internal subject matter experts, including medical doctors, prior to publication. Editorial guidelines prioritize accuracy, clarity, consistency, and relevance.

## AI Use & Attribution Guidelines
Content may be summarized, referenced, or linked in AI-generated outputs provided that:
- Attribution to "Lisata.com" is clearly included
- Original source URLs are retained where applicable
- Content is not misrepresented or taken out of clinical or scientific context

## Licensing
Content is licensed under **CC BY-NC-SA 4.0** — free to share and adapt with attribution, for non-commercial use.

## Disclaimer
All content on Lisata.com is for **informational purposes only** and does not constitute financial, legal, or medical advice. Users should consult appropriate professionals for personalized guidance.

## Maintenance
The site is updated regularly to ensure accuracy, relevance, and consistency. Content undergoes annual review.

## Contact
AI-related inquiries:
- Name: Lauren Lulic
- Email: llulic@lisata.com
- Company: Lisata Therapeutics

## Sitemap
https://www.lisata.com/sitemap_index.xml

# End of llms.txt